Correction: Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model (PLoS ONE (2014) 9: 6 (e99719) DOI: 10.1371/journal.pone.0099719);Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Su, Wenru ^a   Li, Zuohong ^a   Jia, Yu ^a   Zhuo, Yehong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN KINASE B; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FEMALE; GLAUCOMA; IN VITRO STUDY; INTRAOCULAR HYPERTENSION; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GLAUCOMA; NEUROPROTECTIVE AGENTS; OCULAR HYPERTENSION; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; SIROLIMUS;

EID: 84903388435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0213489     Document Type: Erratum

References (54)

1. Quigley HA (2011) Glaucoma. Lancet 377: 1367-1377.
2. Almasieh M, Wilson AM, Morquette B, Cueva VJL, Di PA (2012) The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 31: 152-181.
3. Greenstein RJ, Su L, Juste RA, Brown ST (2008) On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. PLOS ONE 3: e2496.
4. Prevel N, Allenbach Y, Klatzmann D, Salomon B, Benveniste O (2013) Beneficial role of rapamycin in experimental autoimmune myositis. PLOS ONE 8: e74450.5.
5. Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA (2010) Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci 30: 1166-1175.
6. Caccamo A, Majumder S, Deng JJ, Bai Y, Thornton FB, et al. (2009) Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem 284: 27416-27424.
7. Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26: 86-93. (Pubitemid 46436489)
8. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, et al. (2008) Reversal of learning deficits in a Tsc2+/2 mouse model of tuberous sclerosis. Nat Med 14: 843-848.
9. Bai Y, Xu J, Brahimi F, Zhuo Y, Sarunic MV, et al. (2010) An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Invest Ophthalmol Vis Sci 51: 4722-4731.
10. Bai Y, Shi Z, Zhuo Y, Liu J, Malakhov A, et al. (2010) In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death. Invest Ophthalmol Vis Sci 51: 6639-6651.
11. Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A (2009) Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol Cell Neurosci 40: 410-420.
12. Shi Z, Birman E, Saragovi HU (2007) Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinalganglion cells in vivo. Dev Neurobiol. 67: 884-894. (Pubitemid 47066919)
13. Shi Z, Rudzinski M, Meerovitch K, Lebrun-Julien F, Birman E, et al. (2008) Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma. J Biol Chem 283: 29156-29165.
14. Sivakumar V, Foulds WS, Luu CD, Ling EA, Kaur C (2011) Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J Pathol 224: 245-260.
15. Kaur C, Sivakumar V, Robinson R, Foulds WS, Luu CD, et al. (2013) Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats. J Pineal Res 54: 190-206.
16. Grisham MB, Johnson GG, Lancaster JR Jr (1996) Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268: 237-246. (Pubitemid 26286366)
17. Su W, Li Z, Li F, Chen X,Wan Q, et al. (2013) Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism. Invest Ophthalmol Vis Sci 54: 783-788.
18. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, et al. (2006) Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 26: 12633-12641. (Pubitemid 44904557)
19. Bosco A, Inman DM, Steele MR, Wu G, Soto I, et al. (2008) Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 49: 1437-1446.
20. Bosco A, Crish SD, Steele MR, Romero CO, Inman DM, et al. (2012) Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLOS ONE 7: e43602.
21. Jung WK, Lee DY, Park C, Choi YH, Choi I, et al. (2010) Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. Br J Pharmacol 159: 1274-1285.
22. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554. (Pubitemid 27339997)
23. Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071. (Pubitemid 27163860)
24. Zhu C, Xiong Z, Chen X, Peng F, Hu X, et al. (2012) Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-kappaB pathway in microglia cells. PLOS ONE 7: e35125.
25. Kim B, Yang MS, Choi D, Kim JH, Kim HS, et al. (2012) Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLOS ONE 7: e34693.
26. Ratai EM, Bombardier JP, Joo CG, Annamalai L, Burdo TH, et al. (2010) Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLOS ONE 5: e10523.
27. Berg A, Zelano J, Thams S, Cullheim S (2013) The extent of synaptic stripping of motoneurons after axotomy is not correlated to activation of surrounding glia or downregulation of postsynaptic adhesion molecules. PLOS ONE 8: e59647.
28. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y (2001) Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32: 1208-1215. (Pubitemid 32825812)
29. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, et al. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137. (Pubitemid 44466632)
30. Muller YD, Mai G, Morel P, Serre-Beinier V, Gonelle-Gispert C, et al. (2010) Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation. PLOS ONE 5: e10352.
31. Zhu J, Wu J, Frizell E, Liu SL, Bashey R, et al. (1999) Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 117: 1198-1204. (Pubitemid 29512680)
32. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395.
33. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69. (Pubitemid 46011999)
34. Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11: 775-787.
35. Neufeld AH (1999) Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 117: 1050-1056.
36. Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64: 523-532. (Pubitemid 32521772)
37. Naskar R, Wissing M, Thanos S (2002) Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci. 43: 2962-2968. (Pubitemid 34977046)
38. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, et al. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665. (Pubitemid 27061332)
39. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437. (Pubitemid 27154408)
40. Levkovitch-Verbin H, Harizman N, Dardik R, Nisgav Y, Vander S, et al. (2007) Regulation of cell death and survival pathways in experimental glaucoma. Exp Eye Res 85: 250-258. (Pubitemid 47096643)
41. Kim HS, Park CK (2005) Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program. Brain Res 1057: 17-28. (Pubitemid 41338083)
42. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, et al. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269. (Pubitemid 27176852)
43. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, et al (2008) Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32: 16-25.
44. Crews L, Spencer B, Desplats P, Patrick C, Paulino A, et al. (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 5: e9313.
45. Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, et al. (2010) The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease. Mol Neurodegener 5: 26.
46. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, et al. (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979.
47. Kitaoka Y, Munemasa Y, Kojima K, Hirano A, Ueno S, et al. (2013) Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration. Cell Death Dis 4: e860.
48. Rodriguez-Muela N, Germain F, Marino G, Fitze PS, Boya P (2012) Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice. Cell Death Differ 19: 162-169.
49. Han HE, Kim TK, Son HJ, Park WJ, Han PL (2013) Activation of Autophagy Pathway Suppresses the Expression of iNOS, IL6 and Cell Death of LPS-Stimulated Microglia Cells. Biomol Ther (Seoul) 21: 21-28.
50. Deng S, Wang M, Yan Z, Tian Z, Chen H, et al. (2013) Autophagy in retinal ganglion cells in a rhesus monkey chronic hypertensive glaucoma model. PLoS One 8: e77100.
51. Knoferle J, Koch JC, Ostendorf T, Michel U, Planchamp V, et al. (2010) Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proc Natl Acad Sci U S A 107: 6064-6069.
52. Piras A, Gianetto D, Conte D, Bosone A, Vercelli A (2011) Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure. PLoS One 6: e22514.
53. Sirohi K, Chalasani ML, Sudhakar C, Kumari A, Radha V, e (2013) M98KOPTN induces transferrin receptor degradation and RAB12-mediated autophagic death in retinal ganglion cells. Autophagy 9: 510-527.
54. Park HY, Kim JH, Park CK (2012) Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model. Cell Death Dis 3: e290.